MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
Six-month MRI is not recommended owing to its very low csPCa detection rate. The increasing csPCa detection rates at two and five years suggest these are reasonable time points to perform MRI. Prostate biopsy should be performed on all cases with positive MRI, and can safely be deferred in most cases with negative MRI.
Authors
- James Steven Wysock (ORCID: https://orcid.org/0000-0002-7669-0947)
- Eli Rapoport (ORCID: https://orcid.org/0000-0003-3430-3950)
- Samuel I. Parry (ORCID: https://orcid.org/0000-0002-5946-9247)
- Majlinda Tafa (ORCID: https://orcid.org/0009-0004-6788-9411)
- Herbert Lepor
Institutions
- New York University (US)
Publication Details
- Journal
- BJUI Compass
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/bco2.70120
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00